Related Experiment Videos
Leflunomide analogues as potential antiinflammatory agents.
Wen-Hsin Huang1, Chiao-Li Yang, An-Rong Lee
1School of Pharmacy, National Defense Medical Center, Taipei, Taiwan.
Chemical & Pharmaceutical Bulletin
|March 4, 2003
Summary
Researchers explored leflunomide analogues for anti-inflammatory effects. Certain analogues with specific phenyl ring substitutions showed enhanced potency and safety, suggesting potential for new anti-inflammatory drug development.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Immunology
Background:
- Leflunomide is an established disease-modifying antirheumatic drug (DMARD) used for treating inflammatory conditions.
- Understanding structure-activity relationships is crucial for developing more effective and safer anti-inflammatory agents.
Purpose of the Study:
- To synthesize and evaluate novel leflunomide analogues for anti-inflammatory activity.
- To identify structural modifications that enhance potency and improve the safety profile compared to leflunomide.
Main Methods:
- Synthesis of a series of leflunomide analogues.
- Assessment of anti-inflammatory activity using the carrageenan-induced paw edema assay in rodents.
- Determination of LD(50) values in male ICR mice to evaluate acute toxicity.
Main Results:
- Several leflunomide analogues exhibited significantly greater anti-inflammatory potency than the parent compound.
- Analogues with electron-donating or negative inductive groups on the phenyl rings were particularly effective.
- Nonsubstituted analogues or those with chain extension at the 4-position showed reduced activity.
- The most potent analogues (1d, g-j) demonstrated higher LD(50) values than leflunomide and its active metabolite, indicating improved safety.
Conclusions:
- Specific structural modifications of leflunomide can lead to analogues with superior anti-inflammatory activity and a better safety profile.
- These findings highlight promising candidates for further investigation as novel anti-inflammatory therapeutics.